Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
ALHC notice reports proposed resale activity by Andreas P. Wagner under 10b5-1 plans. The filing lists two common-stock sale entries: 21,118 shares on 03/04/2026 for $393,251.97 and 22,238 shares on 02/10/2026 for $455,211.86. Broker information shows Morgan Stanley Smith Barney LLC as executing broker.
Wagner Andreas P. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Human Resources Officer Andreas P. Wagner received an equity grant in the form of restricted stock units. The award covers 23,543 units, each representing one share of common stock. These units vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, contingent on his continued service with the company. Following this grant, Wagner directly holds 172,230 shares of Alignment Healthcare common stock, reflecting both existing ownership and the new award.
Burzacchi Sebastian reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that COO - Mgmt Services Org Sebastian Burzacchi received a grant of 36,198 shares of Common Stock in the form of restricted stock units. These units carry no purchase price and increase his direct holdings to 273,991 shares after the award.
According to the terms, the 36,198 restricted stock units will vest in three approximately equal installments on each of the first three anniversaries of the grant date, as long as Burzacchi continues to provide service to the company on each vesting date. This is a compensation-related equity award rather than an open‑market share purchase.
Mansour Adnan R. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare reported that Chief Digital Officer Adnan R. Mansour received a grant of 25,015 restricted stock units of Common Stock on March 13, 2026. These RSUs vest in roughly one-third increments on each of the first three anniversaries of the grant date, if he continues serving the company. After this award, he directly holds 48,456 shares or units tied to Alignment Healthcare stock. This transaction reflects equity-based compensation rather than an open-market purchase.
JOYCE CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Legal and Administrative Officer Christopher J. Joyce received an equity grant of 51,501 shares of Common Stock in the form of restricted stock units. These units were awarded at no cash cost per share as part of his compensation.
The 51,501 restricted stock units will vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, as long as he continues serving the company through each vesting date. After this grant, he directly holds 348,589 shares of the company’s Common Stock.
Kim Hyong reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Medical Officer Hyong Kim received an equity grant of 52,972 shares of Common Stock in the form of restricted stock units at no cash cost. These units vest in roughly equal thirds on each of the first three anniversaries of the grant date, contingent on continued service. Following this grant, Kim holds 386,105 shares directly, underscoring this as a routine, compensation-related award rather than an open-market purchase.
Head James M reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that its Chief Financial Officer, James M. Head, received a grant of 103,002 restricted stock units of common stock. Each unit represents one share and will vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, contingent on his continued service. Following this award, his direct common stock holdings total 184,595 shares.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported mixed insider activity in Common Stock. On March 13, 2026, she received 161,860 restricted stock units, each representing one share, which will vest in roughly equal thirds on each of the first three anniversaries of the grant date, subject to continued service.
On March 16, 2026, she completed an open-market sale of 30,000 shares at a weighted-average price of $17.4809 per share, with individual sale prices ranging from $17.12 to $17.60. Following the sale, she directly held 1,095,562 shares of Common Stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on May 22, 2025.
KAO JOHN E reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Executive Officer John E. Kao received a grant of 338,434 restricted stock units of Common Stock on March 13, 2026. The grant was made at no cash purchase price as a stock-based compensation award.
Each restricted stock unit represents the right to receive one share of Common Stock and will vest approximately one third on each of the first three anniversaries of the grant date, subject to Mr. Kao’s continued service with the company. Following this grant, he holds 1,857,914 shares directly and 2,472,641 shares indirectly through the JEK Trust, of which he is trustee.
Vorhoff Nicholas Robbert reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. disclosed that director Nicholas Robbert Vorhoff was granted 18,982 restricted stock units, each representing one share of common stock. These units vest on the one-year anniversary of the grant date if he continues serving on the Board.
The filing shows 173,408 common shares credited to his direct holdings after the grant. According to the footnote, the RSUs are held solely for the benefit of General Atlantic Service Company, L.P., and Vorhoff disclaims beneficial ownership of both the RSUs and the underlying common stock.